28.01.2015 18:00:00
|
SuperSonic Imagine Has Signed the Exclusive Distribution Agreement with Konica Minolta
Regulatory News :
SuperSonic Imagine (Paris:SSI) (Euronext : SSI, FR0010526814), a company specializing in ultrasound medical imaging equipment, announces the signing of an exclusive partnership with Konica Minolta, Inc. (Konica Minolta) to distribute its ultrasound system, the Aixplorer®, in Japan.
This partnership significantly increases SuperSonic Imagine’s geographical coverage. Japan is the third largest ultrasound market in the world and is a key part of the company’s global expansion strategy.
"We are very pleased to include SuperSonic Imagine’s Aixplorer ultrasound system in our portfolio of medical imaging solutions. The Aixplorer surpasses the limits of traditional ultrasound.” said Keijiro Asayama General Manager, Ultrasound Business Unit from Konica Minolta. ”Its pioneering technology is in alignment with our own company mission to provide innovative, high quality products to our customers.”
SuperSonic Imagine’s Aixplorer is unique with its UltraFast™ software platform which can acquire images 200 times faster than conventional ultrasound systems. The speed of the UltraFast platform enables SuperSonic Imagine's proprietary ShearWave™ Elastography technology to assess and quantify tissue stiffness in real time. Tissue stiffness is used by physicians to help identify potentially malignant or other diseased tissue.
"SuperSonic Imagine is very proud to be working with Konica Minolta, a prestigious company and ideal partner for expanding the use of our ultrasound technology in Japan.” said Jacques Souquet, Founder and CEO of SuperSonic Imagine, "Our technology provides detailed, real-time information important to the Japanese general imaging marketplace and can be used in a broad range of applications such as breast, thyroid, liver and musculoskeletal exams.”
About SuperSonic Imagine
Founded in 2005 and based in
Aix-en-Provence (France), SuperSonic Imagine is a company specializing
in medical imaging.
The company designs, develops and markets a
revolutionary ultrasound system, Aixplorer®, with an UltraFast™ platform
that can acquire images 200 times faster than conventional ultrasound
systems. Aixplorer® is the only system that can image two types of
waves: ultrasound waves ensure excellent image quality and shear waves,
which allow physicians to visualize and analyze the stiffness of tissue
in a real-time, reliable, reproducible and non-invasive manner. This
innovation, ShearWave™Elastography, significantly improves the detection
and characterization of numerous pathologies in several applications
including breast, thyroid, liver and prostate. SuperSonic Imagine has
been granted regulatory clearances for the commercialization of
Aixplorer® in the main global markets. Over the past years, SuperSonic
Imagine enjoyed the backing of several prestigious investors, among
which Auriga Partners, Edmond de Rothschild Investment Partners,
Bpifrance, Omnes Capital and NBGI.
For more information about SuperSonic Imagine, please go to www.supersonicimagine.com
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Supersonic Imagine SAmehr Nachrichten
Keine Nachrichten verfügbar. |